CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-16 | Brughera Marco Maria Director | Purchase · Common Stock Warrant | +2,500 | $0.00 | $0 | 2,500 |
| 2016-06-16 | Krumeich Karen R SVP and CFO | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2016-06-16 | Brownlie Keith L Director | Grant or award · Stock Option (Right to Buy) | +40,541 | 40,541 | ||
| 2016-06-16 | Brughera Marco Maria Director | Grant or award · Stock Option (Right to Buy) | +40,541 | 40,541 | ||
| 2016-06-16 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +40,541 | 40,541 | ||
| 2016-06-16 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +40,541 | 40,541 | ||
| 2016-06-16 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +40,541 | 40,541 | ||
| 2015-12-31 | Warusz Joseph Michael VP of Finance/Acting CFO | Grant or award · Option (Right to Buy) | +55,000 | 55,000 | ||
| 2015-12-31 | Straube Richard Senior VP and CMO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2015-12-31 | SCHABER CHRISTOPHER J Chairman, CEO and President | Grant or award · Option (Right to Buy) | +140,000 | 140,000 | ||
| 2015-12-31 | Donini Oreola SVP and CSO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2015-12-23 | ZELDIS JEROME B Director | Purchase | +2,500 | $1.27 | $3K | 69,166 |
| 2015-12-22 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +10,000 | $1.29 | $13K | 85,761 |
| 2015-08-31 | LAPOINTE ANTHONY GREGG Director | Exercise or conversion | +25,000 | $0.30 | $8K | 73,781 |
| 2015-08-31 | LAPOINTE ANTHONY GREGG Director | Exercise or conversion · Common Stock Warrant | −25,000 | 0 | ||
| 2015-07-01 | SCHABER CHRISTOPHER J Chairman, CEO and President | Exercise or conversion | +7,143 | $0.61 | $4K | 82,904 |
| 2015-07-01 | SCHABER CHRISTOPHER J Chairman, CEO and President | Exercise or conversion · Common Stock Warrant | −7,143 | 0 | ||
| 2015-06-18 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +19,868 | 19,868 | ||
| 2015-06-18 | Brownlie Keith L Director | Grant or award · Stock Option (Right to Buy) | +19,868 | 19,868 | ||
| 2015-06-18 | Brughera Marco Maria Director | Grant or award · Stock Option (Right to Buy) | +19,868 | 19,868 |
Page 10 of 14 · 277 trades